Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Zambon and Sheffield submit IND for MSI-cromolyn

July 21, 2000

K-5993: a new peptide IL-4 antagonist

July 20, 2000

Triazolo CCR3 receptor antagonists claimed by Toray for Rx of allergic diseases, etc.

July 20, 2000

Purines 2000: a potent and selective A2B antagonist effective in asthma, retinopathy

July 19, 2000

Sankyo claims potent tachykinin antagonist series

July 18, 2000

Cafcit reduces apnea of prematurity

July 17, 2000

Tetracycline derivatives with broad indications reported by CollaGenex

July 12, 2000

PathoGenesis commences phase I trial of AeroDose TOBI

July 12, 2000

Schering-Plough enters asthma collaboration with Texas Biotechnology

July 12, 2000

Orally active human elastase inhibitors developed under collaborative Cortech-Ono effort

July 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.